XML 41 R77.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Information (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract]                        
Revenue $ 308.4 $ 310.8 $ 312.0 $ 325.7 $ 374.7 $ 368.2 $ 368.2 $ 362.8 $ 1,256.9 $ 1,473.9 $ 1,462.4  
Operating costs and expenses                 1,093.1 1,203.8 1,202.9  
Operating income (loss) 40.1 57.7 46.8 19.2 57.9 66.0 65.2 81.0 163.8 270.1 259.5  
Interest expense (income), net                 182.0 218.9 215.0  
Other expense (income), net                 (1.3) 1.7 0.9  
(Loss) income before equity in earnings of subsidiaries and income taxes                 (57.2) 35.9 43.6  
Income tax (benefit) expense                 (2.5) 24.7 25.0  
Net (loss) income (28.1) 9.3 0.8 (36.7) (9.8) 3.9 4.5 12.6 (54.7) 11.2 18.6  
Other comprehensive income (loss)                 76.4 (0.8) (48.9)  
Total comprehensive income (loss)                 21.7 10.4 (30.3)  
Preferred stock dividends                 10.4 10.4 10.4  
Net (loss) income applicable to common shareowners                 (65.1) 0.8 8.2  
Condensed Consolidating Balance Sheets [Abstract]                        
Cash and cash equivalents 4.6       23.6       4.6 23.6 73.7  
Other current assets 1.6       11.6       1.6 11.6    
Total current assets 251.1       303.5       251.1 303.5    
Property, plant and equipment, net 902.8       1,587.4       902.8 1,587.4    
Investment in CyrusOne 471.0       0       471.0 0    
Other noncurrent assets 36.6       86.3       36.6 86.3    
Total assets 2,107.3       2,872.4       2,107.3 2,872.4    
Current portion of long-term debt 12.6       13.4       12.6 13.4    
Accounts payable 89.4       135.6       89.4 135.6    
Other current liabilities 36.8       40.2       36.8 40.2    
Total current liabilities 254.3       355.4       254.3 355.4    
Long-term debt, less current portion 2,252.6       2,676.0       2,252.6 2,676.0    
Other noncurrent liabilities 74.4       176.5       74.4 176.5    
Total liabilities 2,784.0       3,570.6       2,784.0 3,570.6    
Shareowners' (deficit) equity (676.7)       (698.2)       (676.7) (698.2) (715.2) (667.8)
Total liabilities and shareowners' equity (deficit) 2,107.3       2,872.4       2,107.3 2,872.4    
Condensed Consolidating Statements of Cash Flows [Abstract]                        
Cash flows (used in) provided by operating activities                 78.8 212.7 289.9  
Capital expenditures                 (196.9) (367.2) (255.5)  
Dividends received from CyrusOne                 21.3 0 0  
Proceeds from sale of assets                 2.0 1.6 11.5  
Cash divested from deconsolidation of CyrusOne                 (12.2) 0 0  
Other investing activities                 0 0 (0.7)  
Cash flows provided by (used in) investing activities                 (185.4) (371.8) (244.7)  
Proceeds from issuance of long-term debt                 536.0 525.0 0  
Debt issuance costs                 (6.7) (20.9) (0.8)  
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days                 94.2 52.0 0.4  
Repayment of debt                 (530.8) (442.4) (11.5)  
Common stock issuance costs                 0 (5.7) 0  
Common stock repurchase                 0 (0.3) (10.4)  
Proceeds from exercise of options and warrants                 7.1 12.1 0.4  
Other financing activities                 (2.3) (2.8) (16.5)  
Cash flows provided by (used in) financing activities                 87.6 109.0 (48.8)  
(Decrease) increase in cash and cash equivalents                 (19.0) (50.1) (3.6)  
Cash and cash equivalents at beginning of year       23.6       73.7 23.6 73.7 77.3  
Cash and cash equivalents at end of year 4.6       23.6       4.6 23.6 73.7  
Notes guaranteed by parent [Member]
                       
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract]                        
Revenue                 1,256.9 1,473.9 1,462.4  
Operating costs and expenses                 1,093.1 1,203.8 1,202.9  
Operating income (loss)                 163.8 270.1 259.5  
Interest expense (income), net                 182.0 218.9 215.0  
Other expense (income), net                 39.0 15.3 0.9  
(Loss) income before equity in earnings of subsidiaries and income taxes                 (57.2) 35.9 43.6  
Income tax (benefit) expense                 (2.5) 24.7 25.0  
Equity in earnings of subsidiaries, net of tax                 0 0 0  
Net (loss) income                 (54.7) 11.2 18.6  
Other comprehensive income (loss)                 76.4 (0.8) (48.9)  
Total comprehensive income (loss)                 21.7 10.4 (30.3)  
Preferred stock dividends                 10.4 10.4 10.4  
Net (loss) income applicable to common shareowners                 (65.1) 0.8 8.2  
Condensed Consolidating Balance Sheets [Abstract]                        
Cash and cash equivalents 4.6       23.6       4.6 23.6 73.7  
Receivables, net 154.8       199.0       154.8 199.0    
Other current assets 91.7       80.9       91.7 80.9    
Total current assets 251.1       303.5       251.1 303.5    
Property, plant and equipment, net 902.8       1,587.4       902.8 1,587.4    
Investment in CyrusOne 471.0               471.0      
Goodwill and intangibles, net 106.1       487.4       106.1 487.4    
Investments in and advances to subsidiaries 0       0       0 0    
Other noncurrent assets 376.3       494.1       376.3 494.1    
Total assets 2,107.3       2,872.4       2,107.3 2,872.4    
Current portion of long-term debt 12.6       13.4       12.6 13.4    
Accounts payable 89.9       135.6       89.9 135.6    
Other current liabilities 151.8       206.4       151.8 206.4    
Total current liabilities 254.3       355.4       254.3 355.4    
Long-term debt, less current portion 2,252.6       2,676.0       2,252.6 2,676.0    
Other noncurrent liabilities 277.1       539.2       277.1 539.2    
Intercompany payables 0       0       0 0    
Total liabilities 2,784.0       3,570.6       2,784.0 3,570.6    
Shareowners' (deficit) equity (676.7)       (698.2)       (676.7) (698.2)    
Total liabilities and shareowners' equity (deficit) 2,107.3       2,872.4       2,107.3 2,872.4    
Condensed Consolidating Statements of Cash Flows [Abstract]                        
Cash flows (used in) provided by operating activities                 78.8 212.7 289.9  
Capital expenditures                 (196.9) (367.2) (255.5)  
Dividends received from CyrusOne                 21.3      
Proceeds from sale of assets                 2.0 1.6 11.5  
Cash divested from deconsolidation of CyrusOne                 (12.2)      
Other investing activities                 0.4 (6.2) (0.7)  
Cash flows provided by (used in) investing activities                 (185.4) (371.8) (244.7)  
Proceeds from issuance of long-term debt                 536.0 525.0    
Funding between Parent and subsidiaries, net                 0 0 0  
Debt issuance costs                 (6.7) (20.9)    
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days                 94.2 52.0 0.4  
Repayment of debt                 (530.8) (442.4) (11.5)  
Common stock issuance costs                   (5.7)    
Common stock repurchase                   (0.3) (10.4)  
Proceeds from exercise of options and warrants                 7.1 12.1    
Other financing activities                 (12.2) (10.8) (27.3)  
Cash flows provided by (used in) financing activities                 87.6 109.0 (48.8)  
(Decrease) increase in cash and cash equivalents                 (19.0) (50.1) (3.6)  
Cash and cash equivalents at beginning of year       23.6       73.7 23.6 73.7 77.3  
Cash and cash equivalents at end of year 4.6       23.6       4.6 23.6 73.7  
Parent Company [Member] | Notes guaranteed by parent [Member]
                       
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract]                        
Revenue                 0 0 3.4  
Operating costs and expenses                 55.4 33.9 23.6  
Operating income (loss)                 (55.4) (33.9) (20.2)  
Interest expense (income), net                 164.3 164.8 161.8  
Other expense (income), net                 28.2 11.5 (0.9)  
(Loss) income before equity in earnings of subsidiaries and income taxes                 (247.9) (210.2) (181.1)  
Income tax (benefit) expense                 (79.8) (68.3) (56.4)  
Equity in earnings of subsidiaries, net of tax                 113.4 153.1 143.3  
Net (loss) income                 (54.7) 11.2 18.6  
Other comprehensive income (loss)                 76.5 (0.8) (48.8)  
Total comprehensive income (loss)                 21.8 10.4 (30.2)  
Preferred stock dividends                 10.4 10.4 10.4  
Net (loss) income applicable to common shareowners                 (65.1) 0.8 8.2  
Condensed Consolidating Balance Sheets [Abstract]                        
Cash and cash equivalents 2.1       3.8       2.1 3.8 69.6  
Receivables, net 2.6       1.0       2.6 1.0    
Other current assets 4.4       3.1       4.4 3.1    
Total current assets 9.1       7.9       9.1 7.9    
Property, plant and equipment, net 0.1       0.1       0.1 0.1    
Investment in CyrusOne 0               0      
Goodwill and intangibles, net 0       0       0 0    
Investments in and advances to subsidiaries 1,406.6       1,449.9       1,406.6 1,449.9    
Other noncurrent assets 359.1       384.6       359.1 384.6    
Total assets 1,774.9       1,842.5       1,774.9 1,842.5    
Current portion of long-term debt 5.4       0       5.4 0    
Accounts payable 1.5       1.2       1.5 1.2    
Other current liabilities 67.7       85.6       67.7 85.6    
Total current liabilities 74.6       86.8       74.6 86.8    
Long-term debt, less current portion 1,916.1       1,841.7       1,916.1 1,841.7    
Other noncurrent liabilities 214.5       383.3       214.5 383.3    
Intercompany payables 246.4       228.9       246.4 228.9    
Total liabilities 2,451.6       2,540.7       2,451.6 2,540.7    
Shareowners' (deficit) equity (676.7)       (698.2)       (676.7) (698.2)    
Total liabilities and shareowners' equity (deficit) 1,774.9       1,842.5       1,774.9 1,842.5    
Condensed Consolidating Statements of Cash Flows [Abstract]                        
Cash flows (used in) provided by operating activities                 (218.1) (144.8) (139.6)  
Capital expenditures                 0 0 0  
Dividends received from CyrusOne                 0      
Proceeds from sale of assets                 0 0 11.5  
Cash divested from deconsolidation of CyrusOne                 0      
Other investing activities                 0 0 (0.7)  
Cash flows provided by (used in) investing activities                 0 0 10.8  
Proceeds from issuance of long-term debt                 536.0 0    
Funding between Parent and subsidiaries, net                 174.2 433.6 150.3  
Debt issuance costs                 (6.7) (3.6)    
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days                 40.0 0 0  
Repayment of debt                 (522.0) (352.0) 0  
Common stock issuance costs                   0    
Common stock repurchase                   (0.3) (10.4)  
Proceeds from exercise of options and warrants                 7.1 12.1    
Other financing activities                 (12.2) (10.8) (11.3)  
Cash flows provided by (used in) financing activities                 216.4 79.0 128.6  
(Decrease) increase in cash and cash equivalents                 (1.7) (65.8) (0.2)  
Cash and cash equivalents at beginning of year       3.8       69.6 3.8 69.6 69.8  
Cash and cash equivalents at end of year 2.1       3.8       2.1 3.8 69.6  
Cincinnati Bell Telephone Company [Member] | Notes guaranteed by parent [Member]
                       
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract]                        
Revenue                 644.2 642.8 655.8  
Operating costs and expenses                 459.1 436.3 435.6  
Operating income (loss)                 185.1 206.5 220.2  
Interest expense (income), net                 (2.7) (1.5) 3.4  
Other expense (income), net                 6.5 5.9 7.5  
(Loss) income before equity in earnings of subsidiaries and income taxes                 181.3 202.1 209.3  
Income tax (benefit) expense                 66.1 73.8 76.0  
Equity in earnings of subsidiaries, net of tax                 0 0 0  
Net (loss) income                 115.2 128.3 133.3  
Other comprehensive income (loss)                 0 0 0  
Total comprehensive income (loss)                 115.2 128.3 133.3  
Preferred stock dividends                 0 0 0  
Net (loss) income applicable to common shareowners                 115.2 128.3 133.3  
Condensed Consolidating Balance Sheets [Abstract]                        
Cash and cash equivalents 1.8       1.9       1.8 1.9 1.4  
Receivables, net 0       0       0 0    
Other current assets 24.1       34.4       24.1 34.4    
Total current assets 25.9       36.3       25.9 36.3    
Property, plant and equipment, net 706.5       646.7       706.5 646.7    
Investment in CyrusOne 0               0      
Goodwill and intangibles, net 2.3       2.3       2.3 2.3    
Investments in and advances to subsidiaries 247.7       228.2       247.7 228.2    
Other noncurrent assets 6.1       6.3       6.1 6.3    
Total assets 988.5       919.8       988.5 919.8    
Current portion of long-term debt 3.9       3.0       3.9 3.0    
Accounts payable 45.9       61.7       45.9 61.7    
Other current liabilities 49.4       50.2       49.4 50.2    
Total current liabilities 99.2       114.9       99.2 114.9    
Long-term debt, less current portion 141.8       141.3       141.8 141.3    
Other noncurrent liabilities 172.2       138.6       172.2 138.6    
Intercompany payables 0       0       0 0    
Total liabilities 413.2       394.8       413.2 394.8    
Shareowners' (deficit) equity 575.3       525.0       575.3 525.0    
Total liabilities and shareowners' equity (deficit) 988.5       919.8       988.5 919.8    
Condensed Consolidating Statements of Cash Flows [Abstract]                        
Cash flows (used in) provided by operating activities                 239.0 250.4 264.7  
Capital expenditures                 (153.1) (108.8) (106.3)  
Dividends received from CyrusOne                 0      
Proceeds from sale of assets                 2.0 1.4 0  
Cash divested from deconsolidation of CyrusOne                 0      
Other investing activities                 0 0 0  
Cash flows provided by (used in) investing activities                 (151.1) (107.4) (106.3)  
Proceeds from issuance of long-term debt                 0 0    
Funding between Parent and subsidiaries, net                 (84.3) (66.0) (156.5)  
Debt issuance costs                 0 0    
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days                 0 0 0  
Repayment of debt                 (3.7) (76.5) (2.3)  
Common stock issuance costs                   0    
Common stock repurchase                   0 0  
Proceeds from exercise of options and warrants                 0 0    
Other financing activities                 0 0 0  
Cash flows provided by (used in) financing activities                 (88.0) (142.5) (158.8)  
(Decrease) increase in cash and cash equivalents                 (0.1) 0.5 (0.4)  
Cash and cash equivalents at beginning of year       1.9       1.4 1.9 1.4 1.8  
Cash and cash equivalents at end of year 1.8       1.9       1.8 1.9 1.4  
Non-Guarantor Subsidiaries [Member] | Notes guaranteed by parent [Member]
                       
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract]                        
Revenue                 669.0 893.3 860.6  
Operating costs and expenses                 634.9 795.8 801.1  
Operating income (loss)                 34.1 97.5 59.5  
Interest expense (income), net                 20.4 55.6 49.8  
Other expense (income), net                 4.3 (2.1) (5.7)  
(Loss) income before equity in earnings of subsidiaries and income taxes                 9.4 44.0 15.4  
Income tax (benefit) expense                 11.2 19.2 5.4  
Equity in earnings of subsidiaries, net of tax                 0 0 0  
Net (loss) income                 (1.8) 24.8 10.0  
Other comprehensive income (loss)                 (0.1) 0 (0.1)  
Total comprehensive income (loss)                 (1.9) 24.8 9.9  
Preferred stock dividends                 0 0 0  
Net (loss) income applicable to common shareowners                 (1.8) 24.8 10.0  
Condensed Consolidating Balance Sheets [Abstract]                        
Cash and cash equivalents 0.7       17.9       0.7 17.9 2.7  
Receivables, net 152.2       198.0       152.2 198.0    
Other current assets 63.9       43.8       63.9 43.8    
Total current assets 216.8       259.7       216.8 259.7    
Property, plant and equipment, net 196.2       940.6       196.2 940.6    
Investment in CyrusOne 471.0               471.0      
Goodwill and intangibles, net 103.8       485.1       103.8 485.1    
Investments in and advances to subsidiaries 0       0       0 0    
Other noncurrent assets 178.9       266.3       178.9 266.3    
Total assets 1,166.7       1,951.7       1,166.7 1,951.7    
Current portion of long-term debt 3.3       10.4       3.3 10.4    
Accounts payable 42.5       72.7       42.5 72.7    
Other current liabilities 34.6       69.7       34.6 69.7    
Total current liabilities 80.4       152.8       80.4 152.8    
Long-term debt, less current portion 194.7       693.0       194.7 693.0    
Other noncurrent liabilities 59.0       181.7       59.0 181.7    
Intercompany payables 199.7       276.4       199.7 276.4    
Total liabilities 533.8       1,303.9       533.8 1,303.9    
Shareowners' (deficit) equity 632.9       647.8       632.9 647.8    
Total liabilities and shareowners' equity (deficit) 1,166.7       1,951.7       1,166.7 1,951.7    
Condensed Consolidating Statements of Cash Flows [Abstract]                        
Cash flows (used in) provided by operating activities                 57.9 107.1 164.8  
Capital expenditures                 (43.8) (258.4) (149.2)  
Dividends received from CyrusOne                 21.3      
Proceeds from sale of assets                 0 0.2 0  
Cash divested from deconsolidation of CyrusOne                 (12.2)      
Other investing activities                 0.4 (6.2) 0  
Cash flows provided by (used in) investing activities                 (34.3) (264.4) (149.2)  
Proceeds from issuance of long-term debt                 0 525.0    
Funding between Parent and subsidiaries, net                 (89.9) (367.6) 6.2  
Debt issuance costs                 0 (17.3)    
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days                 54.2 52.0 0.4  
Repayment of debt                 (5.1) (13.9) (9.2)  
Common stock issuance costs                   (5.7)    
Common stock repurchase                   0 0  
Proceeds from exercise of options and warrants                 0 0    
Other financing activities                 0 0 (16.0)  
Cash flows provided by (used in) financing activities                 (40.8) 172.5 (18.6)  
(Decrease) increase in cash and cash equivalents                 (17.2) 15.2 (3.0)  
Cash and cash equivalents at beginning of year       17.9       2.7 17.9 2.7 5.7  
Cash and cash equivalents at end of year 0.7       17.9       0.7 17.9 2.7  
Consolidation, Eliminations [Member] | Notes guaranteed by parent [Member]
                       
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract]                        
Revenue                 (56.3) (62.2) (57.4)  
Operating costs and expenses                 (56.3) (62.2) (57.4)  
Operating income (loss)                 0 0 0  
Interest expense (income), net                 0 0 0  
Other expense (income), net                 0 0 0  
(Loss) income before equity in earnings of subsidiaries and income taxes                 0 0 0  
Income tax (benefit) expense                 0 0 0  
Equity in earnings of subsidiaries, net of tax                 (113.4) (153.1) (143.3)  
Net (loss) income                 (113.4) (153.1) (143.3)  
Other comprehensive income (loss)                 0 0 0  
Total comprehensive income (loss)                 (113.4) (153.1) (143.3)  
Preferred stock dividends                 0 0 0  
Net (loss) income applicable to common shareowners                 (113.4) (153.1) (143.3)  
Condensed Consolidating Balance Sheets [Abstract]                        
Cash and cash equivalents 0       0       0 0 0  
Receivables, net 0       0       0 0    
Other current assets (0.7)       (0.4)       (0.7) (0.4)    
Total current assets (0.7)       (0.4)       (0.7) (0.4)    
Property, plant and equipment, net 0       0       0 0    
Investment in CyrusOne 0               0      
Goodwill and intangibles, net 0       0       0 0    
Investments in and advances to subsidiaries (1,654.3)       (1,678.1)       (1,654.3) (1,678.1)    
Other noncurrent assets (167.8)       (163.1)       (167.8) (163.1)    
Total assets (1,822.8)       (1,841.6)       (1,822.8) (1,841.6)    
Current portion of long-term debt 0       0       0 0    
Accounts payable 0       0       0 0    
Other current liabilities 0.1       0.9       0.1 0.9    
Total current liabilities 0.1       0.9       0.1 0.9    
Long-term debt, less current portion 0       0       0 0    
Other noncurrent liabilities (168.6)       (164.4)       (168.6) (164.4)    
Intercompany payables (446.1)       (505.3)       (446.1) (505.3)    
Total liabilities (614.6)       (668.8)       (614.6) (668.8)    
Shareowners' (deficit) equity (1,208.2)       (1,172.8)       (1,208.2) (1,172.8)    
Total liabilities and shareowners' equity (deficit) (1,822.8)       (1,841.6)       (1,822.8) (1,841.6)    
Condensed Consolidating Statements of Cash Flows [Abstract]                        
Cash flows (used in) provided by operating activities                 0 0 0  
Capital expenditures                 0 0 0  
Dividends received from CyrusOne                 0      
Proceeds from sale of assets                 0 0 0  
Cash divested from deconsolidation of CyrusOne                 0      
Other investing activities                 0 0 0  
Cash flows provided by (used in) investing activities                 0 0 0  
Proceeds from issuance of long-term debt                 0 0    
Funding between Parent and subsidiaries, net                 0 0 0  
Debt issuance costs                 0 0    
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days                 0 0 0  
Repayment of debt                 0 0 0  
Common stock issuance costs                   0    
Common stock repurchase                   0 0  
Proceeds from exercise of options and warrants                 0 0    
Other financing activities                 0 0 0  
Cash flows provided by (used in) financing activities                 0 0 0  
(Decrease) increase in cash and cash equivalents                 0 0 0  
Cash and cash equivalents at beginning of year       0       0 0 0 0  
Cash and cash equivalents at end of year 0       0       0 0 0  
Various Cincinnati Bell Telephone Notes [Member]
                       
Debt Instruments [Abstract]                        
Cincinnati Bell Telephone Notes Outstanding $ 134.5       $ 134.5       $ 134.5 $ 134.5